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A B S T R A C T
Malignant melanoma often involves the heart in patients with advanced tumor disease but isolated
cardiac metastasis is rare. We describe successful removal of isolated metastasis in the right ventricular
outﬂow tract of a 64-year-old woman with exertional dyspnea and prior history of melanoma. She
remains asymptomatic for 3 years after surgery while median survival is about 3 months after diagnosis
without treatment. This report should promote early surgery in order to relieve symptoms and improve
survival.
<Learning objective: Metastatic melanoma has an ominous prognosis, particularly in case of
widespread disease and cardiac localization. When isolated metastasis of the heart is present the optimal
treatment remains controversial, either chemotherapy, surgery, or both. As shown in this case, long-term
favorable outcomes can be obtained when isolated surgery of obstructive cardiac metastasis is
performed, even incomplete.>
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Metastatic melanoma limited to the heart is rare and cardiac
metastasis is often associated with widely metastatic disease.
Hence cardiac treatment is mostly palliative. We report conserva-
tive surgery of isolated obstructive melanoma metastasis of the
right ventricle. Three years after uncomplicated surgery the
patient remains symptomless.
Case report
In October 2010 a 64-year-old women presented with a 3-
month history of isolated exertional dyspnea. Clinical examination
showed a blood pressure of 120/70 mmHg, a grade III pansystolic
murmur at the lower left sternal border, a right-sided S4 gallop, and
no signs of congestive heart failure except dyspnea. She had no
history of previous heart disease.
Electrocardiography and chest radiography were unremarkable.
Ulcerated malignant melanoma of the right arm had been
removed in July 2009; the lesion was Clarke’s level V, Breslow’s
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echodense mass in the ventricular outﬂow tract with a functional
stenosis (max gradient 60 mmHg) and a dilated right ventricle
(Fig. 1). Transesophageal echocardiography revealed a 5 cm  3 cm
mass, attached via a pedicle to the upper and anterior part of the
interventricular septum in the right ventricle. Full body computed
tomography (CT) scan conﬁrmed the mass and revealed no
extracardiac metastasis.
Isolated metastatic melanoma limited to the heart was strongly
suspected and surgical resection was performed 3 days later.
The patient underwent a median sternotomy with transverse
section of the pulmonary artery on cardiopulmonary bypass. A
friable mass attached to the apical septum, obstructing the right
ventricular outﬂow tract, was excised piecemeal but was not
totally removed (Fig. 2, panel A). Complete ablation would have
necessitated major cardiac reconstruction, which was considered
too hazardous in this context. No other lesions were detected in the
right ventricle or atrium.
Microscopic examination revealed malignant neoplasm com-
posed of atypical fusiform and epithelioid cells. Scattered cells
display melanin pigmentation in their cytoplasms, these cells
strongly expressed HMB45, a melanocyte speciﬁc marker (Fig. 2,
panels B and C).
The postoperative course was uncomplicated except for the
occurrence of complete right bundle block branch. The patient wass reserved.
Fig. 1.
Transthoracic echocardiography shows dilated right ventricle (RV), a large echodense mass in the ventricular outﬂow tract () with a functional stenosis (max
gradient 60 mmHg). Aorta (AO), left atrium (LA), left ventricle (LV), and pericardium were normal.
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complete relief of her dyspnea and disappearance of cardiac
murmur.
A postoperative TTE examination demonstrated a
8 mm  13 mm residual tumor in the right ventricle due to
incomplete removal.Fig. 2.
Macroscopic aspect of the friable tumor excised piecemeal (panel A). Microscop
eosin–saffron stain. Scattered cells display melanin pigmentation in their cytop
speciﬁc marker (panel C).A positron emission tomography scan performed after surgery
conﬁrmed isolated right ventricular hypermetabolism and no
extracardiac extension of melanoma (Fig. 3).
In view of these ﬁndings, she received from December 2010
adjuvant dacarbazine chemotherapy, discontinued in March 2011
after 3 cycles due to low tolerance (hypotension and nausea).ic examination revealed atypical fusiform and epithelioid cells with hematoxylin–
lasms (black arrow, panel B), these cells strongly expressed HMB45, a melanocyte-
Fig. 3.
Post-operative positron emission tomography scan with ﬂudeoxyglucose
(18F) showed right ventricular hypermetabolism due to incomplete
removal of the tumor, rib cage hypermetabolism due to sternotomy and
no extracardiac extension of melanoma.
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chemotherapy with ipilimumab was considered, but rejected by
the patient. Annual follow-up with TTE examination revealed non-
progressive tumor.
In January 2014, TTE was performed while the patient remained
symptomless. Clinical examination showed recurrent soft systolic
murmur and no signs of heart failure. TTE examination showed
small regrowth of tumor in the right ventricle, which was slightly
obstructive. Full body CT scan revealed no extracardiac metastasis.
Second-line chemotherapy with ipilimumab was still refused by
the patient.
Discussion
Malignant melanoma often involves the heart with a 50%
incidence of cardiac deposits at necropsy, often associated with
widespread tumor dissemination [1]. ‘‘Melanotic heart’’ tends to
affect all four chambers of the heart but the right atrium is mainly
involved [2]. In the early stage of the disease patients remain
symptomless and clinical features are unspeciﬁc (as tachycardia,
dyspnea, and edema), making early diagnosis difﬁcult.
TTE is extensively used to detect cardiac metastasis. CT scan and
magnetic resonance imaging (with characteristic hyper-intensesignal on T1-weighted images) can also be useful, size and
extension of tumor growth being determined more precisely than
by sonography [3].
Metastatic melanoma limited to the heart is rare and cardiac
metastasis is often associated with late presentations and widely
metastatic disease. Cardiac treatment is mostly palliative, hence
early detection of isolated forms has important therapeutic and
prognosis implications. Indeed surgical removal should be
considered as ﬁrst-line therapy for isolated and symptomatic
cardiac metastasis, in an attempt to relieve symptoms even if total
resection is impossible [4,5].
In this report, cardiac involvement is the ﬁrst clinical event of
metastatic malignancy, with no extracardiac metastasis, providing
reasons for the surgical decision. Cardiac involvement was
conﬁrmed by TTE only a year after resection of the malignant
melanoma. Surprisingly the patient remained asymptomatic for 3
years after surgery, which is exceptional.
Some might discuss the role of chemotherapy on disease
progression. However, only three cycles were completed, which is
probably not the cause of this favorable evolution.
Conclusion
In conclusion isolated cardiac metastasis from malignant
melanoma is rare and median survival is about 3 months after
diagnosis without treatment [6,7]. This report should promote
early surgery for isolated and symptomatic cardiac metastasis in
order to relieve symptoms and improve survival.
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